The degree of clinical agreement among physicians on the presence or absence of generalized lymphadenopathy was assessed in 32 randomly selected participants from a prospective study of male sexual contacts of men with acquired immunodeficiency syndrome (AIDS) or an AIDS-related condition (ARC) [8]. The total number of palpable lymph nodes was assessed by each of three physicians. Results from two of the three physicians are presented in Table 8.15.
Suppose the results of Problem 8.41 show no significant difference. Does this mean this type of assessment is highly reproducible? Why or why not?
Table 8.15 Reproducibility of assessment of number of palpable lymph nodes among sexual contacts of AIDS or ARC patients
Perform the test in Problem 8.40, and report a p-value.
Want to see the full answer?
Check out a sample textbook solutionChapter 8 Solutions
Fundamentals of Biostatistics
- A study was conducted to examine if children with autism spectrum disorder (ASD) had higher prenatal exposure to air pollution, specifically particulate matter < 2.5 g in diameter (PM2.5). Researchers obtained birth records of all children born in Los Angeles between 2000 and 2008 and linked these to the Department of Developmental Services records to determine if any of those subjects had been diagnosed with ASD or not. They used the birth addresses given in the birth records to determine the average daily PM2.5 for the third trimester for each child. The standard deviation for PM2.5 among ASD subjects was found to be 34.6 and for non-ASD subjects was 16.8. Assume PM2.5 is normally distributed. 4a. What was the study design? * Randomized Clinical Trial (RCT) * Case Report * Nested Case-Control Study * Case-Control Study * cross-sectional study Cohort Study 4B. What are the null and alternative hypotheses? 4c. What type of statistical test would you use to analyze the…arrow_forwardLow-Birth-Weight Hospital Stays. Data on low-birthweight babies were collected over a 2-year period by 14 participating centers of the National Institute of Child Health and Human Development Neonatal Research Network. Results were reported by J. Lemons et al. in the on-line paper “Very Low Birth Weight Outcomes of the National Institute of ChildHealth and Human Development Neonatal Research Network” (Pediatrics, Vol. 107, No. 1, p. e1). For the 1084 surviving babies whose birth weights were 751– 1000 grams, the average length of stay in the hospital was 86 days, although one center had an average of 66 days and another had an average of 108 days. a. Can the mean lengths of stay be considered population means? Explain your answer.b. Assuming that the population standard deviation is 12 days, determine the z-score for a baby’s length of stay of 86 days at the center where the mean was 66 days.c. Assuming that the population standard deviation is 12 days, determine the z-score for a…arrow_forwardThe article “Differences in Susceptibilities of Different Cell Lines to Bilirubin Damage” (K. Ngai, C. Yeung, and C. Leung, Journal of Paediatric Child Health, 2000:36–45) reports an investigation into the toxicity of bilirubin on several cell lines. Ten sets of human liver cells and 10 sets of mouse fibroblast cells were placed into solutions of bilirubin in albumin with a 1.4 bilirubin/albumin molar ratio for 24 hours. In the 10 sets of human liver cells, the average percentage of cells surviving was 53.9 with a standard deviation of 10.7. In the 10 sets of mouse fibroblast cells, the average percentage of cells surviving was 73.1 with a standard deviation of 9.1. Find a 98% confidence interval for the difference in survival percentages between the two cell lines.arrow_forward
- J 2 RCT was conducted to evaluate efficacy and safety of drug simvastatin compared to placebo in reducing mortality and morbidity in patients with coronary heart disease. Subjects were followed up on average 5.4 years. Over the duration of the follow-up, 63 subjects died due to heart attack among 2,223 subjects in the placebo group compared to 30 deaths among 2,221 patients in the simvastatin drug group. 1. What is the Relative Risk or death from the heart attack in the simvastatin group?arrow_forwardA survey of 90 recently delivered women on the rolls of a county welfare department revealed that 27 had a history of intrapartum or postpartum infection. Can we conclude that the population proportion with a history of intrapartum or postpartum infection is significantly less than or equal to 0.25? Let alpha = 0.05.arrow_forwardConsider number of male doctors in military and civilian hospitals. Test claim there is a smaller proportion of male doctors in military than in civilian life at alpa= 0.05 Military 1 Civilian 2 Male doctors 358 6786 Total doctors 407 7363 a. At the 0.05 level of significance, the data provides insufficient evidence to conclude that the population proportion of male military doctors is less than the population proportion of male civilian doctors. b. At the 0.05 level of significance, the data provides sufficient evidence to conclude that the population proportion of male military doctors is more than the population proportion of male civilian doctors. c. At the 0.05 level of significance, the data provides insufficient evidence to conclude that the population proportion of male military doctors is more than the population proportion of male civilian doctors. d. At the 0.05 level of significance, the data provides sufficient evidence to conclude…arrow_forward
- A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 2 2 4 6 New Drug 1 2 2 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug 1 1 1 1 1.5 1.5 2 2 2 2 4.5 4.5 2 2 2 2 4.5 4.5 4 3 3 7 6 7 4 8 6…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by PatientsOld Drug 1 2 2 4 6 New Drug 1 2 2 3 7Old Drug New Drug Total Sample(Ordered Smallest to Largest) RanksOld Drug New Drug Old Drug New DrugR1= R2= A) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 12.5 is greater than the critical U value of 2.B) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05…arrow_forward
- A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 2 2 4 6 New Drug 1 2 2 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug 1 1 1 1 1.5 1.5 2 2 2 2 4.5 4.5 2 2 2 2 4.5 4.5 4 3 3 7 6 7 4 8 6…arrow_forward
- MATLAB: An Introduction with ApplicationsStatisticsISBN:9781119256830Author:Amos GilatPublisher:John Wiley & Sons IncProbability and Statistics for Engineering and th...StatisticsISBN:9781305251809Author:Jay L. DevorePublisher:Cengage LearningStatistics for The Behavioral Sciences (MindTap C...StatisticsISBN:9781305504912Author:Frederick J Gravetter, Larry B. WallnauPublisher:Cengage Learning
- Elementary Statistics: Picturing the World (7th E...StatisticsISBN:9780134683416Author:Ron Larson, Betsy FarberPublisher:PEARSONThe Basic Practice of StatisticsStatisticsISBN:9781319042578Author:David S. Moore, William I. Notz, Michael A. FlignerPublisher:W. H. FreemanIntroduction to the Practice of StatisticsStatisticsISBN:9781319013387Author:David S. Moore, George P. McCabe, Bruce A. CraigPublisher:W. H. Freeman